MTRA - ETF AI Analysis
Top Page
Invesco International Growth Focus ETF (MTRA)
MTRA, the Invesco International Growth Focus ETF, has a solid but not top-tier rating, reflecting a mix of strong growth leaders and some holdings with notable risks. High-quality names like ASML, Tencent, and ResMed support the fund’s rating through robust revenue and profit growth and strategic investments in advanced technologies, even though some trade at expensive valuations. At the same time, holdings such as Sartorius Stedim Biotech, BAE Systems, and Alibaba face issues like bearish or mixed technical trends, cash flow pressures, and rich valuations, and the fund’s focus on international growth stocks means investors are exposed to sector and regional swings as well as higher volatility from premium-priced companies.
MTRA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 129.69M
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.54%
- Beta
- 1.16
- Issuer
- Invesco
- Inception Date
- Jun 11, 2025
- Dividend Yield
- 0.71%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
MTRA Summary
The Invesco International Growth Focus ETF (MTRA) is an actively managed fund that looks for fast-growing companies outside the U.S., rather than tracking a set index. It invests across many countries, including the UK, France, the Netherlands, and more, and holds well-known names like ASML and Alibaba. This ETF may appeal to investors who want long-term growth and broader global diversification instead of only owning U.S. stocks. However, because it focuses on growth companies in international markets, its price can be more volatile and can go up and down significantly with global market conditions.
How much will it cost me?
The Invesco International Growth Focus ETF (MTRA) has an expense ratio of 0.54%, which means you’ll pay $5.40 per year for every $1,000 invested. This is higher than average because the fund is actively managed, requiring more research and analysis to select stocks. Active management often leads to higher costs compared to passively managed funds that track an index.
What would affect this ETF?
The Invesco International Growth Focus ETF (MTRA) could benefit from global economic recovery and increased demand for innovative technologies, healthcare advancements, and industrial growth, as these sectors make up a significant portion of its holdings. However, potential risks include geopolitical tensions, regulatory changes in key regions, and currency fluctuations, which could negatively impact the performance of its international investments. Additionally, rising interest rates or economic slowdowns in major markets could challenge growth-focused companies in the ETF.
MTRA Top 10 Holdings
MTRA leans heavily on international growth leaders, with Dutch chip-equipment giant ASML and France’s Schneider Electric doing much of the heavy lifting as their shares keep climbing. Industrial names like Siemens and Ferguson are also rising, giving the fund a solid backbone in Europe’s manufacturing and infrastructure story. On the flip side, Chinese tech titans Tencent and Alibaba are losing steam, acting as a drag despite their long-term potential. Overall, the ETF is globally diversified but tilted toward European industrials and growth names outside the U.S.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 7.46% | $9.66M | EUR 539.67B | 50.70% | 76Outperform |
 DE:SIE | Siemens | 3.43% | $4.44M | EUR 202.50B | 7.55% | 74Outperform |
 GB:FERG | Ferguson PLC | ― | ― | ― | ― | ―― |
 FR:SU | Schneider Electric | 1.58% | $2.04M | EUR 140.06B | -4.62% | 62Neutral |
 HK:0700 | Tencent Holdings | ― | ― | ― | ― | 75Outperform |
 RMD | Resmed | ― | ― | ― | ― | 76Outperform |
 FR:DIM | Sartorius Stedim Biotech | 2.89% | $3.74M | EUR 21.74B | 8.03% | 61Neutral |
 GB:BA | BAE Systems | 1.66% | $2.16M | GBP 60.55B | 11.26% | 61Neutral |
 CH:LONN | Lonza Group Ltd | 3.18% | $4.13M | CHF 43.90B | 15.37% | 71Outperform |
 BABA | Alibaba | 1.28% | $1.66M | $246.17B | -43.63% | 68Neutral |
MTRA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MTRA, the sentiment is Negative. The current price of 25.20 is below the 20-day moving average (MA) of 25.89, below the 50-day MA of 26.40, and below the 200-day MA of 26.21, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 42.33 is Neutral, neither overbought nor oversold. The STOCH value of 38.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTRA.
MTRA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MTRA | $25.20 | $27.00(7.16% Upside) | $129.69M | 0.54% | 57Neutral |
 OSEA | $29.81 | $37.02(24.20% Upside) | $370.76M | 0.55% | 71Outperform |
 AVDS | $76.15 | ― | $379.08M | 0.30% | 59Neutral |
 UMMA | $35.43 | $49.22(38.91% Upside) | $308.87M | 0.65% | 62Neutral |
 QLTI | $27.76 | $33.01(18.91% Upside) | $283.55M | 0.60% | 61Neutral |
 IDYN | $29.59 | $35.33(19.40% Upside) | $113.38M | 0.45% | 59Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MTRA | Invesco International Growth Focus ETF | 25.20 | -0.96 | -3.66% | |
| OSEA | Harbor International Compounders ETF | 29.81 | -0.36 | -1.19% | |
| AVDS | Avantis International Small Cap Equity ETF | 76.15 | 10.96 | 16.81% | |
| UMMA | Wahed Dow Jones Islamic World ETF | 35.43 | 6.72 | 23.42% | |
| QLTI | GMO International Quality ETF | 27.76 | 1.94 | 7.53% | |
| IDYN | iShares International Equity Factor Rotation Active ETF | 29.59 | 2.88 | 10.77% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.